Edition:
United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

27.95HKD
20 Aug 2019
Change (% chg)

HK$0.80 (+2.95%)
Prev Close
HK$27.15
Open
HK$26.75
Day's High
HK$28.45
Day's Low
HK$26.75
Volume
7,138,490
Avg. Vol
6,206,719
52-wk High
HK$41.05
52-wk Low
HK$25.70

Lu, Jun 

Mr. Lu Jun serves as Vice President of Sinopharm Group Co., Ltd. Mr. Lu joined the Group in January 2003, and has been a vice president of the Company since June 2004. He served as the assistant to the general manager of the Company, the general manager of medicine retail business department and the head of the investment department of the Company concurrently from April 2003 to June 2004. Mr. Lu has over 43 years of working experience, over 20 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Lu obtained an executive master’s degree in business administration in Antai College of Economics and Management of Shanghai Jiao Tong University in December 2009. Mr. Lu was qualified as a senior economist. Mr. Lu taught at the Second Military Medical University from March 1980 to August 1998, and was previously the general manager of Sinopharm Group Shanghai Likang Medicine Co., Ltd. and Sinopharm Holding Guoda Drug Stores Co., Ltd. from August 1998 to June 2008. Mr. Lu is currently the director of Sinopharm Group Shanxi Co., Ltd. and Sinopharm-CICC (Shanghai) Medical & Healthcare Investment Management Co., Ltd., and chairman of Sichuan Pharmaceutical Group Co., Ltd. of CNPGC, Sinopharm Holding Jiangsu Co., Ltd., Sinopharm Holding Wuxi Co., Ltd., Sinopharm Holding Anhui Co., Ltd., Sinopharm Holding Changzhou Co., Ltd., Sinopharm Holding Zhejiang Co., Ltd., Sinopharm Holding Wenzhou Co., Ltd., Sinopharm Group Chemical Reagent Co., Ltd., Sinopharm Lingyun Biopharmaceutical (Shanghai) Co., Ltd. and Sinopharm Holding Hutchison Whampoa Pharmaceutical (Shanghai) Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li

6,572,000

Yong Liu

7,489,000

Qiyu Chen

--

Xiuchang Jiang

--

Maisong Cai

--

Jun Lu

--
As Of  31 Dec 2017